Egan James 4/A
4/A · Sucampo Pharmaceuticals, Inc. · Filed Oct 1, 2009
Insider Transaction Report
Form 4/AAmended
Egan James
Chief Operating Officer
Transactions
- Award
Employee Stock Option (Right to buy)
2009-09-23+60,000→ 60,000 totalExercise: $5.87Exp: 2019-09-23→ Class A common stock (60,000 underlying)
Footnotes (2)
- [F1]This report is being filed to amend the incorrect vesting start dates.
- [F2]With regard to 30,000 shares of Class A common stock underlying the option, vesting commences on September 23, 2012 in four equal annual installments and with regard to the balance of 30,000 shares of Class A common stock underlying the option, vesting commences on September 23, 2013 in four equal annual installments.